Synthesis and Antiproliferative Screening Of Novel Analogs of Regioselectively Demethylated Colchicine and Thiocolchicine

被引:14
作者
Czerwonka, Dominika [1 ]
Sobczak, Szymon [2 ]
Maj, Ewa [3 ]
Wietrzyk, Joanna [3 ]
Katrusiak, Andrzej [2 ]
Huczynski, Adam [1 ]
机构
[1] Adam Mickiewicz Univ, Fac Chem, Dept Med Chem, Uniwersytetu Poznanskiego 8, PL-61614 Poznan, Poland
[2] Adam Mickiewicz Univ, Dept Mat Chem, Fac Chem, Uniwersytetu Poznanskiego 8, PL-61614 Poznan, Poland
[3] Polish Acad Sci, Hirszfeld Inst Immunol & Expt Therapy, Rudolfa Weigla 12, PL-53114 Wroclaw, Poland
关键词
colchicine analogs; thiocolchicine; colchiceine; antimitotic agents; antiproliferative activity; hydrates; BIOLOGICAL EVALUATION; ANTITUMOR AGENTS; BINDING-SITE; TUBULIN; DESIGN; DERIVATIVES;
D O I
10.3390/molecules25051180
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
070307 [化学生物学]; 071010 [生物化学与分子生物学];
摘要
Colchicine, a pseudoalkaloid isolated from Colchicum autumnale, has been identified as a potent anticancer agent because of its strong antimitotic activity. It was shown that colchicine modifications by regioselective demethylation affected its biological properties. For demethylated colchicine analogs, 10-demethylcolchicine (colchiceine, 1) and 1-demethylthiocolchicine (3), a series of 12 colchicine derivatives including 5 novel esters (2b-c and 4b-d) and 4 carbonates (2e-f and 4e-f) were synthesized. The antiproliferative activity assay, together with in silico evaluation of physicochemical properties, confirmed attractive biological profiles for all obtained compounds. The substitutions of H-donor and H-acceptor sites at C1 in thiocolchicine position provide an efficient control of the hydration affinity and solubility, as demonstrated for anhydrate 3, hemihydrate 4e and monohydrate 4a.
引用
收藏
页数:12
相关论文
共 46 条
[1]
Alkadi Hourieh, 2018, Infectious Disorders - Drug Targets, V18, P105, DOI 10.2174/1871526517666171017114901
[2]
TUBULIN BOUND TO COLCHICINE FORMS POLYMERS DIFFERENT FROM MICROTUBULES [J].
ANDREU, JM ;
TIMASHEFF, SN .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1982, 79 (22) :6753-6756
[3]
[Anonymous], 2008, Med. Chem. Anticancer Drugs, DOI DOI 10.1016/B978-0-444-52824-7.X0001-7
[4]
Interaction of novel thiocolchicine analogs with the tubulin isoforms from bovine brain [J].
Banerjee, A ;
Kasmala, LT ;
Hamel, E ;
Sun, L ;
Lee, KH .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 254 (02) :334-337
[5]
BLADEFONT A, 1979, AFINIDAD, V36, P329
[6]
The conversion of colchicine into colchiceine [J].
Boyland, E ;
Mawson, EH .
BIOCHEMICAL JOURNAL, 1938, 32 :1204-1206
[7]
Design, synthesis and identification of novel colchicine-derived immunosuppressant [J].
Chang, Dong-Jo ;
Yoon, Eun-Young ;
Lee, Geon-Bong ;
Kim, Soon-Ok ;
Kim, Wan-Joo ;
Kim, Young-Myeong ;
Jung, Jong-Wha ;
An, Hongchan ;
Suh, Young-Ger .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (15) :4416-4420
[8]
Recent Development and SAR Analysis of Colchicine Binding Site Inhibitors [J].
Chen, Jing ;
Liu, Tao ;
Dong, Xiaowu ;
Hu, Yongzhou .
MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2009, 9 (10) :1174-1190
[9]
Colchicine in clinical medicine. A guide for internists [J].
Cocco, Giuseppe ;
Chu, David C. C. ;
Pandolfi, Stefano .
EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2010, 21 (06) :503-508
[10]
CORTESE F, 1977, J BIOL CHEM, V252, P1134